Announcements Trials
Browse Landscape

Phase

Phase 2 135Phase 1 90Phase 1/2 48Phase 3 35Phase NA 4Phase EARLY_PHASE1 4Phase 4 3Phase 2/3 3

Status

Completed 3Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Thoracic 1

Conditions

Lung Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Completed × Ipilimumab × Clear all
NCT04513522 2025-07-11

CheckMate 7C9

Bristol-Myers Squibb

Phase 4 Completed
101 enrolled 12 charts
Genitourinary

Kidney Neoplasms

NCT02869789 2023-06-15

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

Bristol-Myers Squibb

Phase 4 Completed
1,041 enrolled 18 charts
Thoracic

Lung Neoplasms

NCT02982954 2022-11-01

CHECKMATE 920

Bristol-Myers Squibb

Phase 4 Completed
211 enrolled 21 charts
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡